Agrawal A. Pharmacological Prevention of Severe Respiratory Syncytial Virus Infection in High-Risk Infants and Children: Maternal Immunization and Long-Acting Monoclonal Antibodies. Indian J Pharm Drug Studies. 2025;4(3):95-101. Accessed November 15, 2026. https://mansapublishers.com/ijpds/article/view/8496